Main content 1 Menu 2 Search 3 Footer 4
+A
A
-A
High contrast
HOME JOURNAL JOURNAL SELECTION NETWORK HELP ABOUT

Journal Selection Criteria and Standards

WPRIM Journal Selection Criteria (August 2023)

NJSC Philippines Selection Criteria (for Philippine-based journals only)

Minimum standards for the suspension and removal of WPRIM approved journals

Application and Indexing Process

Application and Submission Process for WPRIM Indexing

Journal Content Management

Candidate Journal Selection and Data Creation and Management System

Tumor

1981  to  Present  ISSN: 1000-7431

Articles

About

Save Email

Sort by

Best match
Relevance
PubYear
JournalTitle

DISPLAY OPTIONS

Format:

Per page:

Save citations to file

Selection:

Format:

Create file Cancel

Email citations

To:

Please check your email address first!

Selection:

Format:

Send email Cancel

1918

results

page

of 192

1

Cite

Cite

Copy

Share

Share

Copy

The dual role and research status of autophagy in colorectal cancer

Chengxiang YANG ; Yan LI

Tumor.2024;44(3):252-261. doi:10.3781/j.issn.1000-7431.2024.2308-0444

Colorectal cancer(CRC)is one of the most common malignant tumors of the digestive system whose incidence is increasing year by year.Autophagy is a process of intracellular self-degradation under stress conditions and plays dual roles by inhibiting or promoting the occurrence,development,recurrence,metastasis,and treatment sensitivity of CRC under different conditions.This review summarizes the roles of autophagy in the occurrence,development,recurrence,and metastasis of CRC,as well as its influence on the immune microenvironment and therapeutic efficacy,proposed potential autophagy-related therapeutic targets,in the hope to provide new ideas for the treatment of CRC.

2

Cite

Cite

Copy

Share

Share

Copy

Exploration of molecular mechanisms and targeted therapies for KRAS mutations in pancreatic ductal adenocarcinoma

Yongzhi CHEN ; Yanjing LI ; Yingbin LIU

Tumor.2024;44(3):278-289. doi:10.3781/j.issn.1000-7431.2024.2402-0083

Pancreatic ductal adenocarcinoma is a highly malignant gastrointestinal tumour with increasing incidence,and KRAS(KRAS Proto-Oncogene,GTPase)gene mutation is the main driver of its development.Pancreatic ductal adenocarcinomas with different types of KRAS mutations show significant differences in their molecular features and clinical manifestations.Given the critical role of KRAS gene mutations in the progression of pancreatic ductal adenocarcinoma,the development of targeted drugs against KRAS mutations has been a research hot spot.This review has comprehensively summarized the molecular features and clinical characteristics of pancreatic ductal adenocarcinomas with different KRAS mutations,discussed in detail the targeted drugs developed against these mutations and their applications in clinical treatment,outlooked the future perspectives of the development of therapeutic strategies.

3

Cite

Cite

Copy

Share

Share

Copy

Advances in the research of exosomes in castration-resistant prostate cancer

Qi CHEN ; Liang DONG ; Wei XUE

Tumor.2024;44(3):290-295. doi:10.3781/j.issn.1000-7431.2024.2402-0095

Exosomes are extracellular vesicles released by living cells,characterized by typical lipid bilayer structure,with diameters ranging between 30 nm and 200 nm.By transferring biomacromolecules and modulating related signaling pathways,exosomes play a role in the development and progression of tumors,including tumor cell proliferation,angiogenesis,tumor microenvironment remodeling,metastatic niche establishment,and drug resistance.Exosomes associated with prostate cancer significantly contribute to the promotion of the transition of prostate cancer to a castration-resistant phenotype.This article primarily summarizes the latest advances in the research of exosomes in castration-resistant prostate cancer.

4

Cite

Cite

Copy

Share

Share

Copy

Advances in imaging examinations for axillary lymph node status assessment in breast cancer patients

Ling LI ; Zhanyu PAN

Tumor.2024;44(3):296-305. doi:10.3781/j.issn.1000-7431.2024.2311-0621

The reduction in surgical axillary lymph node dissection has emerged as a notable trend in the surgical management of breast cancer.In the recent years,with the release of the ten-year data from prospective randomized controlled clinical trials,such as Z0011,NSABP B-32,and AMAROS,in which surgical intervention was primarily utilized,an increasing number of breast cancer patients have been spared from axillary lymph node dissection.Nevertheless,the inclusion criteria employed in these studies rooted in the clinical assessment of axillary lymph node-negative patients who were subsequently validated through sentinel lymph node biopsy,confirming the absence of axillary lymph node metastasis or the presence of 1-2 positive axillary lymph nodes.The accurate preoperative prediction and selection of axillary lymph node-negative patients,with the aim of minimizing unnecessary sentinel lymph node biopsy,continues to be a pertinent concern within the realm of breast cancer surgery.Diverse imaging modalities,including mammography,ultrasound imaging,CT,MRI,and PET-CT,have been widely adopted in the evaluation of breast cancer patients,showing substantial potential in the preoperative assessment of axillary lymph node status.This review provides an overview of the advancement in preoperative axillary lymph node status assessment for breast cancer patients using these imaging techniques.

5

Cite

Cite

Copy

Share

Share

Copy

The role of energy metabolism control in immune regulation after liver transplantation for hepatocellular carcinoma

Linna GAO ; Yangyang TANG ; Yifan LIU ; Tonghai XING

Tumor.2025;45(2):142-150. doi:10.3781/j.issn.1000-7431.2025.2405-0293

Liver cancer stands as one of the most lethal malignant tumors globally,and liver transplantation presents a potent and effective therapeutic approach for affected individuals.However,the post-transplantation immune regulation is critical for the survival of the graft and the long-term prognosis of the patient.Energy metabolism plays a pivotal role in both the tumor microenvironment and immunomodulation following liver transplantation.This review explores the metabolic mechanisms within the tumor microenvironment,energy metabolism characteristics in liver transplantation,and the impact of post-transplantation energy metabolism on reducing liver cancer recurrence and mitigating transplant rejection.By gaining an in-depth comprehension of the intricate interplay between metabolic pathways and immune regulation,it is envisioned that innovative therapeutic strategies can be formulated.These strategies aim to enhance the outcomes for liver transplant recipients and offer more efficacious treatment options for those afflicted with liver cancer.

6

Cite

Cite

Copy

Share

Share

Copy

Microsatellite instability-high metastatic gastric cancer treated with immunotherapy combined with chemotherapy:A case report and literature review

Zhihong XU ; Qian ZHANG ; Hui JIN

Tumor.2025;45(2):137-141. doi:10.3781/j.issn.1000-7431.2025.2306-0314

Gastric cancer is one of the malignant tumors with strong invasion and heterogeneity.Individualized treatment of gastric cancer based on precise classification guidance is currently a research hotspot.Microsatellite instability-high(MSI-H)gastric cancer has specific clinical features,tumor microenvironment,and pathological characteristics,which have been used as tumor markers to evaluate the prognosis of gastric cancer patients.In recent years,immunotherapy has brought new hope for the treatment of gastric cancer patients,among whom MSI-H patients are considered the advantageous population for immunotherapy.This paper reports a case of MSI-H metastatic gastric cancer receiving immunotherapy combined with chemotherapy,and provides reference for clinical practice based on literature review.

7

Cite

Cite

Copy

Share

Share

Copy

The application and research progress in porphyrins and their derivatives in tumor therapy

Ziyu YANG ; Jiekeng LAO ; Huaqing LIN

Tumor.2025;45(2):151-158. doi:10.3781/j.issn.1000-7431.2025.2404-0204

Porphyrin and its derivatives exhibit diverse biochemical properties because of their unique molecular structures,and have been widely used and recognized in the field of tumor therapy.The applications of chemical modifications and nanotechnology have not only significantly enhanced the biological activity of porphyrins and their derivatives but also substantially improved the drug delivery efficiency.In addition,the applications of porphyrins and their derivatives in multiple therapeutic methods,including photodynamic therapy(PDT),sonodynamic therapy(SDT),radiotherapy and immunotherapy,have opened the door for the implementation of tumor multimodal treatment strategies.This cross-disciplinary integration facilitates the overcoming of limitations inherent to single-modality treatments,thereby synergistically enhancing overall therapeutic efficacy aganist tumors.This review systematically summarizes recent advances in the applications of porphyrins and their derivatives within the aforementioned therapeutic treatments,and the challenges and future development potential of porphyrins and their derivatives in tumor therapy are respectively discussed and prospected.

8

Cite

Cite

Copy

Share

Share

Copy

Design and functional validation of protein binders targeting ErbB2

Fan XU ; Yali LIU ; Yongning HE

Tumor.2025;45(2):101-110. doi:10.3781/j.issn.1000-7431.2025.2503-0167

Objective:To design protein binders of human epidermal growth factor receptor-2(HER2,also known as ErbB2)using de novo protein design and to preliminarily evaluate their biological effects on tumor cells.Methods:Based on de novo protein design strategy,RosettaDesign and ProteinMPNN algorithms were used to design the binding proteins targeting ErbB2.Concurrently,AlphaFold was applied to assess structural accuracy of the protein binders and their interactions with ErbB2.Subsequently,yeast surface display technology combined with dual-fluorescence high-throughput flow cytometry were performed to screen for protein binders which were capable of specifically binding to ErbB2 specifically.Selected binding proteins were expressed and purified in Eschrichia coli system.Bio-layer interferometry(BLI)was used to validate the binding specificity of the purified protein binders to ErbB2.Finally,Western blotting and CCK-8 assay were used to evaluate the effects of the candidate binding protein on the downstream signaling of ErbB2 and cell proliferation capacity in ovarian cancer(SK-OV-3)and pancreatic cancer(BxPC-3)cell lines,respectively.Results:In this study,the protein binders targeting ErbB2 were successfully designed,a corresponding binding protein library was established,and a protein binder that specifically binds to ErbB2 was screened out from the library.After BLI verification,this protein binder could effectively bind to ErbB2.Further investigation revealed that in ErbB2-high-expressing SK-OV-3 and BxPC-3 cells,this protein binder could effectively inhibit cell proliferation and reduce the phosphorylation level of AKT,a signaling molecule downstream of ErbB2.Conclusion:Based on the strategy of de novo protein design,this study successfully constructed a protein binder that can effectively bind to ErbB2.The binder can effectively inhibit the activation of the downstream signaling pathway mediated by ErbB2 and the proliferation of tumor cells.This indicates the potential application value of de novo designed protein binders targeting ErbB2 in cancer therapy,providing a novel research approach for the field of targeted tumor therapy.

9

Cite

Cite

Copy

Share

Share

Copy

The regulatory role of endoplasmic reticulum stress-related long non-coding RNA Gm9795 in hepatocellular carcinoma

Mingming WANG ; Weiwei SHANG ; Guoping ZHAO

Tumor.2025;45(2):111-125. doi:10.3781/j.issn.1000-7431.2025.2309-0472

Objective:To investigate the role of endoplasmic reticulum stress(ERS)-related long non-coding RNA(lnc RNA)Gm9795 in the progression of hepatocellular carcinoma(HCC).Methods:This retrospective cohort study included 80 HCC patients who underwent routine surgical procedures at Nanjing Jiangning Hospital from 2014 to 2020.Colecting clinical datas from all patients and using real-time fluorescence quantitative PCR to detect the expression level of Gm9795 in 80 patients'cancer and adjacent tissues,as well as in HCC cells(HepG2,Hep3B,HCCLM3,and Huh7).The correlation between Gm9795 expression and overall survival time and recurrence free survival time of HCC patients was analysised.Constructing HCCLM3 cells overexpressing Gm9795 through lentiviral infection,and constructing Huh7 cells silencing Gm9795 expression through liposome transfection.The proliferation ability of cells was evaluated using CCK-8 assay and colony formation assay,while the migration and invasion ability of cells were detected using Transwell assay.Identification of Gm9795 specific binding protein by mass spectrometry(MS).The effect of overexpressing or silencing Gm9795 expression on the expression of C/EBP homologous protein(CHOP)gene was detected by Western blotting.The CHOP gene was simultaneously transferred into HCCLM3 cells overexpressing Gm9795,and the effects of up-regulating CHOP expression level on the proliferation,migration,and invasion of HCCLM3 cells were evaluated using CCK-8 assay,colony formation assay,and Transwell assay.Results:Compared with adjacent tissues,the expression level of Gm9795 was significantly up-regulated in HCC tissues(P<0.001).The expression levels of Gm9795 in all HCC cells were significantly higher than in normal hepatocytes LO2(all P<0.05).Higher expression levels of Gm9795 were associated with aggressive clinical pathological features,including tumor size,multiple tumors,Barcelona Clinic Liver Cancer(BCLC)staging,and portal vein tumor thrombus(all P<0.05).The results of multivariate analysis showed that high expression level of Gm9795 was an independent prognostic factor for overall survival and recurrence free survival in HCC patients(both P<0.05).The higher expression of Gm9795 was significantly correlated with shorter overall survival and recurrence free survival in the cohort(both P<0.01).Compared with the Vector group,the proliferation,migration,and invasion of HCCLM3 cells were significantly enhanced in the Gm9795 overexpression group(all P<0.01);Compared with the siNC group,the proliferation,migration,and invasion of Huh7 cells were significantly reduced in the siGm9795-1 and siGm9795-2 groups(all P<0.01).CHOP was identified as a Gm9795 specific binding protein by MS.Compared with the Gm9795+Vector group,the Gm9795+CHOP group showed significant reductions in proliferation,migration,and invasion of HCCLM3 cells(all P<0.01).Conclusions:Gm9795 is up-regulated in HCC tissues,and the high expression of Gm9795 is an independent prognostic factor for the overall survival of HCC patients.Gm9795 promotes the proliferation and invasion of HCC cells in vitro,and its mechanism may be related to the inhibition of ERS mediated by CHOP signaling pathway.

10

Cite

Cite

Copy

Share

Share

Copy

Strategies for diagnosis and treatment of multiple primary malignancies:A case report of heterochronous double primary cancer

Feng JIAO ; Yongchao WANG ; Yongheng SHI ; Liwei WANG

Tumor.2025;45(2):126-136. doi:10.3781/j.issn.1000-7431.2024.2406-0337

Objective:To explore the diagnosis and treatment strategies of multiple primary malignancies(MPM).Methods:The medical records and the process of diagnosis and treatment of a patient with heterochronous double primary cancer were retrospectively analyzed,and the treatment strategy was discussed by multi-disciplinary team(MDT).Results:A female patient with heterochronous double primary cancer was reported.The first primary tumor was gastric cancer and the second primary tumor was lung cancer.The first primary tumor was diagnosed at 67 years of age,and the interval between the first primary tumor and second primary tumor was 13 months.Pleural metastasis and pelvic metastasis occurred during the follow-up.Pleural metastasis originated from lung cancer,and pelvic metastasis was considered as gastric cancer implantation.Tumor MDT discussion was conducted at each stage of diagnosis and treatment,and the histopathological diagnosis was confirmed by puncture biopsy or surgical resection.The patient received systemic therapy combined with local treatment for metastases of different tumors and had a longer overall survival(67 months).Side effects were tolerable,and the quality of life was satisfactory throughout the treatment period.Conclusion:For patients with MPM,it is necessary to actively carry out MDT discussion,clarify the histopathological diagnosis,evaluate the clinicopathological and metastatic characteristics,and implement active and effective treatment.

Country

China

Publisher

ElectronicLinks

http://www.tumorsci.org/CN

Editor-in-chief

E-mail

tumor@tumorsci.org

Abbreviation

Tumor

Vernacular Journal Title

肿瘤

ISSN

1000-7431

EISSN

Year Approved

2013

Current Indexing Status

Currently Indexed

Start Year

1981

Description

Related Sites

WHO WPRO GIM

Help Accessibility
DCMS Web Policy
CJSS Privacy Policy

Powered by IMICAMS( 备案号: 11010502037788, 京ICP备10218182号-8)

Successfully copied to clipboard.